Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Moore Michael

2. Date of Event Requiring Statement (MM/DD/YYYY) 12/31/2020

3. Issuer Name and Ticker or Trading Symbol

VIEMED HEALTHCARE, INC. [VMD]

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
President /

(Street)

LAFAYETTE, LA 70508

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	1737483	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options	⁽¹⁾	1/4/2028	Common Shares	130539.0	$2.27 ⁽²⁾	D
Stock Options	⁽³⁾	1/17/2029	Common Shares	207226.0	$5.49 ⁽²⁾	D
Stock Options	⁽⁴⁾	1/17/2030	Common Shares	156673.0	$7.44 ⁽²⁾	D
Restricted Share Units	⁽⁵⁾	1/4/2021	Common Shares	99243.0	$0.0 ⁽⁶⁾	D

Explanation of Responses:
(1)	Options granted to reporting person on January 4, 2018, which vest in three equal installments beginning on the first anniversary of the grant date.
(2)	Denominated and reported in Canadian dollars.
(3)	Options granted to reporting person on January 17, 2019, which vest in three equal installments beginning on the first anniversary of the grant date.
(4)	Options granted to reporting person on January 17, 2020, which vest in three equal installments beginning on the first anniversary of the grant date.
(5)	Restricted Share Units granted to reporting person on January 4, 2018, which vest on January 4, 2021.
(6)	Each Restricted Share Unit represents the conditional right to receive one share of common stock and may be settled in common shares or a cash payment equal to the fair market value of common shares, or a combination thereof.

Remarks:
As the Company no longer qualifies as a foreign private issuer, effective January 1, 2021, the Company's officers, directors, and principal shareholders are subject to Section 16 of the Securities Exchange Act of 1934 ("Exchange Act"). Previously, the Company has determined that it qualified as a foreign private issuer under the Exchange Act and has made use of the foreign private issuer accommodations under U.S. securities laws.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Moore Michael 625 E. KALISTE SALOOM RD. LAFAYETTE, LA 70508			President